RP Singh, EX Fu, SD Smith, DR Williams, PK … - British Journal of Ophthalmology, 2009 - bjo.bmj.com Chorodial neovascularisation (CNV) is the primary cause of vision loss in
exudative age-related macular degeneration (AMD). Recently, short-term
retrospective case series noted visual improvement in patients treated with ... Related articles - All 3 versions
- ►prsjournal.com L Arias, JM Caminal, L Casas, C Masuet, MB … - British Medical Journal, 2008 - bjo.bmj.com Aims: The aim of this study was to compare two treatment options for choroidal
neovascularisation (CNV) secondary to age-related macular degeneration (AMD):
(1) bevacizumab administered once a month for 3 months and thereafter as ... Cited by 8 - Related articles - All 14 versions
GM Orfila - elcomprimido.com Page 1. Modelo de informe de evaluación GÉNESIS-SEFH. Versión nº 3.0 Julio
2008 1 Comisión de Evaluación de Medicamentos RANIBIZUMAB ... Related articles - View as HTML
… , PJ ROSENFELD, CA PULIAFITO, W FEUER … - Retina, 2009 - journals.lww.com KIMBERLY E. STEPIEN, MD, PHILIP J. ROSENFELD, MD, PHD, CARMEN A. PULIAFITO, MD,
MBA, WILLIAM FEUER, MS, WEI SHI, MS, LUMA AL-ATTAR, MD, SANDER R. DUBOVY, MD,
TIMOTHY G. MURRAY, MD, JANET L. DAVIS, MD, WEN-HSIANG LEE, MD, PHD, STEPHEN ... Related articles - All 5 versions
C Zehetner, MT Kralinger, GF Kieselbach - Spektrum der Augenheilkunde, 2008 - Springer Summary. Purpose: To compare and review the effective- ness and safety of
intravitreal injections of ranibizumab and bevacizumab for neovascular
age-related macular degenera- tion. Methods: We reviewed the clinical ... Cited by 1 - Related articles
L Wu, J Fernando Arevalo, M Maia, MH … - Japanese Journal of Ophthalmology, 2009 - Springer Choroidal neovascularization (CNV) is responsible for 80% to 90% of cases of
severe vision loss due to age-related macular degeneration (AMD). 1–3 Vascular
endothelial growth factor (VEGF) appears to play a major role in the ... Related articles - All 2 versions
- ►prsjournal.com K Fong, N Kirkpatrick, Q Mohamed, RL … - Clinical & Experimental Ophthalmology, 2008 - prsjournal.com Results: A total of 109 eyes of 109 patients were treated. The mean age was 82
years, and the mean follow-up period was 9.4 months (range 6-12 months). At
baseline, the mean VA was 45.6 letters (6/37.5) and mean central retinal ... Cited by 1 - Related articles - Cached - All 4 versions
- ►prsjournal.com I Krebs, P Haas, F Zeiler, S Binder - British Journal of Ophthalmology, 2008 - bjo.bmj.com Results: The scans of 233 eyes of 117 patients were evaluated (39.3% were men
and 60.7% women, with a mean age of 76.9 years). Overall, in 57.1% both lines
were positioned correctly. False-positioned lines were recorded in 9.0% due ... Cited by 7 - Related articles - All 6 versions
J Levy, M Shneck, S Rosen, I Klemperer, D … - International Ophthalmology, 2009 - Springer Abstract Objective To report the visual and anatomic outcome of intravitreal
bevacizumab (Avastin) injec- tions in the treatment of subfoveal neovascular
age-related macular degeneration (AMD). Methods Interventional, ... Cited by 5 - Related articles - All 2 versions
